{"id":3906,"date":"2025-03-31T18:11:52","date_gmt":"2025-03-31T18:11:52","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/desmopressin-txt\/"},"modified":"2025-03-31T18:11:52","modified_gmt":"2025-03-31T18:11:52","slug":"desmopressin-txt","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/desmopressin-txt\/","title":{"rendered":"Desmopressin.txt"},"content":{"rendered":"<h1> Desmopressin<\/h1>\n<p><H3>  CLINICAL USE <\/H3><br \/>\nDiabetes insipidus Nocturnal enuresis Post-biopsy bleeding (unlicensed  indication)Pre-biopsy prophylaxis (unlicensed  indication)<H3> DOSE IN NORMAL RENAL FUNCTION  <\/H3>Diabetes insipidus: Oral: 0.2\u20131.2 mg daily  in 3 divided doses. IV: 1\u20134 mcg daily. Inhaled: 10\u201340 mcg in 1 or 2 divided doses. Sub-lingual: 120\u2013720 mcg dailyNocturnal enuresis: Oral: 200\u2013400 mcg at  bedtime, Biopsy: Males \u2013 16 mcg; Females \u2013 12 mcg  or 300\u2013400 nanograms\/kg Pre-biopsy prophylaxis in uraemic  patients: 20 mcg (IV) over 30 minutes<H3>  PHARMACOKINETICS    <\/H3><LI> Molecular weight &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :1069.2<\/li>\n<li>  %Protein binding  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp  &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :0<\/li>\n<li>  %Excreted unchanged in urine &amp;nbsp &amp;nbsp : 45<\/li>\n<p><LI> Volume of distribution (L\/kg) &amp;nbsp &amp;nbsp &amp;nbsp :0.2\u20130.41<\/li>\n<p><LI>half-life \u2013 normal\/ESRD (hrs)&amp;nbsp &amp;nbsp &amp;nbsp :Inhaled: 55 minutes; Oral: 2.8 hours; IV: 51\u2013158 minutes\/\u2013<H3>  DOSE IN RENAL IMPAIRMENT <\/H3> <H4>GFR (mL\/MIN)<\/H4><LI> 20 to 50  &amp;nbsp &amp;nbsp : Dose as in normal renal function <LI> 10 to 20  &amp;nbsp &amp;nbsp : Dose as in normal renal function <LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : Dose as in normal renal function <H3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES  <\/H3><LI> CAPD  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp:Unlikely to be dialysed. Dose as in normal renal function <\/p>\n<li> HD &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :Unlikely to be dialysed. Dose as in normal renal function <LI>HDF\/high flux  &amp;nbsp :Unknown dialysability. Dose as in normal renal function <LI>CAV\/VVHD  &amp;nbsp &amp;nbsp &amp;nbsp:Unlikely to be dialysed. Dose as in normal renal function <H3> IMPORTANT DRUG INTERACTIONS  <\/H3>Potentially hazardous interactions with other drugsNone known <H3> ADMINISTRATION  <\/H3><H4> Reconstition<\/H4>Dilute dose to 50 mL with sodium chloride  0.9% <H4>  Route  <\/H4>IV, intranasally, oral, SC, IM, SL <H4>  Rate of Administration  <\/H4>Over 20\u201360 minutes <H4>Comments<\/H4>Do not inject at a faster rate \u2013 greater risk  of tachyphylaxisIn patients with ischaemic heart disease,  infuse more slowly \u2013 increased risk of acute ischaemic event<H4>  OTHER INFORMATION  <\/H4>Emergency treatment of more generalised  bleeding unresponsive to normal treatments: 0.1\u20130.5 micrograms\/kg 4 times a day + IV conjugated oestrogens (premarin) 0.6 mg\/kg\/day for up to 5 days DDAVP works as a haemostatic by  stimulating factor VIII production Onset of action less than 1 hour. Duration  of effect 4\u20138 hours<br \/>\n","protected":false},"excerpt":{"rendered":"<p>Desmopressin CLINICAL USE Diabetes insipidus Nocturnal enuresis Post-biopsy bleeding (unlicensed<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-3906","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/3906","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=3906"}],"version-history":[{"count":0,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/3906\/revisions"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=3906"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=3906"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=3906"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}